Nihon Kohden Corporation (OTCMKTS:NHNKY) Sees Significant Decline in Short Interest

Nihon Kohden Corporation (OTCMKTS:NHNKY) saw a significant decrease in short interest in the month of April. As of April 30th, there was short interest totaling 21,619 shares, a decrease of 90.5% from the April 15th total of 226,933 shares. Approximately 0.0% of the company’s stock are sold short. Based on an average daily volume of 54,689 shares, the short-interest ratio is currently 0.4 days.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on NHNKY shares. UBS Group raised Nihon Kohden from a “hold” rating to a “strong-buy” rating in a research note on Monday, January 19th. Zacks Research raised Nihon Kohden to a “hold” rating in a research note on Monday, April 27th. One investment analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Buy”.

Nihon Kohden Stock Down 0.2%

Shares of OTCMKTS NHNKY traded down $0.02 during trading on Wednesday, reaching $9.03. The company had a trading volume of 6,154 shares, compared to its average volume of 27,950. Nihon Kohden has a 12-month low of $8.93 and a 12-month high of $14.21. The stock has a market cap of $1.54 billion, a PE ratio of 17.08 and a beta of 0.41. The business’s 50-day moving average is $9.48 and its 200 day moving average is $10.55.

Nihon Kohden Company Profile

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.